Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1219130-25-2

Post Buying Request

1219130-25-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1219130-25-2 Usage

General Description

6-((2,2-diMethyl-1,3-dioxolan-4-yl)Methoxy)pyrazin-2-aMine is a chemical compound with a molecular formula C10H16N2O3. It is an important building block in organic synthesis and pharmaceutical research. The compound contains a pyrazine ring with a methoxy group and a dioxolane ring, as well as a secondary amine functional group. It is commonly used as a reagent in the preparation of various pharmaceuticals, agrochemicals, and other fine chemicals. The compound has potential applications in the development of new drugs and biologically active compounds due to its unique structure and reactivity. Overall, 6-((2,2-diMethyl-1,3-dioxolan-4-yl)Methoxy)pyrazin-2-aMine is an important chemical with diverse applications in the field of organic and medicinal chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 1219130-25-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,9,1,3 and 0 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1219130-25:
(9*1)+(8*2)+(7*1)+(6*9)+(5*1)+(4*3)+(3*0)+(2*2)+(1*5)=112
112 % 10 = 2
So 1219130-25-2 is a valid CAS Registry Number.

1219130-25-2Downstream Products

1219130-25-2Relevant articles and documents

BICYCLIC PYRIDINES AND ANALOGS AS SIRTUIN MODULATORS

-

Page/Page column 78, (2011/06/16)

Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1219130-25-2